IMS works with a variety of media outlets and trade associations to share expertise on issues impacting the pharmaceutical industry. This section provides abstracts and PDFs of current published articles, as well as extracts from recent industry presentations.

Page: <<  1  2  3  4  5  6  7  8  9  10   >>

Postlaunch Strategy Development: Using Patient-Flow Models to Identify Areas of Opportunity
Marketers can combine anonymous patient-level data and primary market research to develop patient flow models that will allow them to identify opportunities to maximize product utilization.
Aug 1, 2005

Prelaunch Strategy Development Identification of Unmet Needs in the Marketplace
Marketers can use anonymous patient-level data to segment patients on a variety of behaviors and clinical factors, revealing potential unmet needs in the process.
Jul 1, 2005

Anonymous Patient-Level Data and Primary Market Research: A Powerful Combination
By combining insights from anonymous patient-level data and primary market research, marketers are better able to design strategies aimed at growing market share.
Jun 1, 2005

The Japanese Pharmaceutical Industry - On the Road to Change
IMS's Ray Hill discusses Japan's pharmaceutical market place in "Think On"--The Corporate Magazine of ALTANA AG.
May 27, 2005

Yen for Mergers
To keep pace with larger Western players, Japanese pharma is exploring merger and acquisition activity and geographic expansion.  IMS Health's Raymond Hill, Vice Present, IMS Health Asia Pacific and Japan explains.
May 27, 2005

Big Ideas in Little Pharma
2004 was a remarkable year for pharma, not so much in terms of its growth--which failed to hit double digits for the first time in years--but for the events that challenged the industry and catalyzed change.
May 1, 2005

Product Positioning to Managed Markets: Part 2
Formulary positioning, as it relates to both access (drug tier) and member contribution (copay), will continue to be a critical commercialization issue for the pharmaceutical industry.
May 1, 2005

Accessing Treatment Patterns in Complex Disease Markets: An Example From the Mental Health Market
Assessing the use of pharmacotherapy in the mental health market can be challenging for marketers, given the fact that the drugs used to treat mental illness may be used across a number of different diagnoses, and in various combinations.
Apr 1, 2005

Assessing Market Response to the Positioning of a Drug
Pharamceutical companies spend millions of dollars on market research, clinical trials, and consultants as they seek to develop the optimal positioning for their products.
Mar 1, 2005

Making the Case to Managed Care
Skyrocketing prescription drug costs and increasing public pressure to minimize premium rate increases have caused managed care companies to take a much more selective stance on drug expenditures.
Feb 1, 2005

Page: <<  1  2  3  4  5  6  7  8  9  10   >>

Home | Contact | Search | Site Map | FAQ | Privacy | Websites
Copyright © 2007 IMS Health Incorporated. All rights reserved.